Susan Wan

2.8k citations

30 papers · 1.5k indexed · h-index 14

Impact in

Internal Medicine top 1%
- Venous Thromboembolism Diagnosis and Management
Transplantation top 5%
- Renal Transplantation Outcomes and Treatments

Papers in

Transplantation 5
- Renal Transplantation Outcomes and Treatments 5
Nephrology 5
- Renal Diseases and Glomerulopathies 3
- Renal function and acid-base balance 2

Co-authors: John W. Eikelboom Daniel J. Quinlan Giancarlo Agnelli David Sebag‐Montefiore Helen Meadows Rob Glynne‐Jones John Northover JA Ledermann
Journals: Journal of Clinical Oncology (5 papers)Transplant International (2 papers)Transplantation (2 papers)Chemical Engineering Journal (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)
Partner nations: United Kingdom Australia China

In The Last Decade

Susan Wan

30 papers receiving 1.5k citations

Peers

Countries citing papers authored by Susan Wan

Since Specialization

Citations

This map shows the geographic impact of Susan Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Wan more than expected).

Fields of papers citing papers by Susan Wan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Wan. The network helps show where Susan Wan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Susan Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Susan Wan Line = papers co-authored together Susan Wan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Risk Factors for the Development of BK Polyomavirus and Treatment Outcomes in Kidney Transplant Recipients: An 8‐Year Retrospective Cohort Study Nephrology ·李程成, Melanie Wyld, Susan Wan, Rebecca J. Davis, Kushani Jayasinghe, Kate Wyburn	2025	1
2	Rational design of “ship-in-a-bottle” evaporator with integrated solar evaporation and photocatalytic degradation for sustainable water treatment Chemical Engineering Journal ·Р Е Филатов, Ting Zhang, Xiaoman Zhang, 家本修, Xiaodan Liu, Susan Wan, H. J. Kim, Jianhui Sun, Shuying Dong, Chongfei Yu, Yongfa Zhu	2025	10
3	Piceatannol upregulates USP14-mediated GPX4 deubiquitination to inhibit neuronal ferroptosis caused by cerebral ischemia-reperfusion in mice Food and Chemical Toxicology ·R. G. DAVLETOV, Xinya Wang, Hans Henning, Shuxian Guo, Xiaojia Liu, Susan Wan, Yubiao Guo, กรผกา อรรคนิตย์, Wen-Cheng Shen, aakanksha shisodia, Liuyi Dong	2025	2
4	Enhanced generation and effective utilization of H2O2 for simultaneous aging of plastics in the C3N4/Vis-LED system with the addition of phenol Chemical Engineering Journal ·Xiaoman Zhang, Ting Zhang, Р Е Филатов, Susan Wan, Xiaodan Liu, Jianhui Sun, Yuling Zhao, Shuying Dong, Xianfa Su, Maohong Fan	2024	8
5	ABO Incompatible Kidney Transplantation Without B-cell Depletion is Associated With Increased Early Acute Rejection: A Single-Center Australian Experience Transplant International ·Jonathan M. Bleasel, Susan Wan, Steven J. Chadban, Tracey Ying, David M. Gracey, 文孝山根, Sarah E. Byerly, Zainab Alqallaf, Гончаров Александр Иванович, Kate Wyburn	2023	1
6	Development and outcomes of de novo donor-specific antibodies in low, moderate, and high immunological risk kidney transplant recipients American Journal of Transplantation ·Susan Wan, Steven J. Chadban, Alice Lepouze, Kate Wyburn	2019	23
7	The Treatment of Antibody-Mediated Rejection in Kidney Transplantation Transplantation ·Susan Wan, Tracey Ying, Kate Wyburn, Darren M. Roberts, Melanie Wyld, Steven J. Chadban	2018	108
8	The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity Cancer Immunology Immunotherapy ·Fiona Thistlethwaite, David E. Gilham, Ryan D. Guest, Dominic G. Rothwell, Manon Pillai, Deborah J. Burt, 战勤葛, Н. А. Кириллова, Juan W. Valle, Surinder K. Sharma, Kerry Chester, Nigel Westwood, Sarah Halford, Stephen Nabarro, Susan Wan, Eric Austin, Robert E. Hawkins	2017	303
9	Evaluation of a visual tool co-developed for training hospital staff on the prevention and control of the spread of healthcare associated infections Infection Disease & Health ·Alastair Macdonald, Colin Macduff, Sylvie Villeneuve Parpay, Susan Wan	2017	5
10	A phase I dose escalation study of the tolerability of the oral VEGFR and EGFR inhibitor vandetanib in combination with the oral MEK1/2 inhibitor selumetinib in solid tumors Annals of Oncology ·Simon Pacey, Fiona Blackhall, Javier García-Corbacho, Deusdedit Ruhangariyo, Alberto Fusi, Sanjeev Kumar, O. Köbner, О М Нікіпелова, Ruth Elizabeth, Sarah Halford, Musshaf Al Imam, Aakanksha, Susan Wan, Denis Talbot	2016	1
11	Trends in the characteristics, dose-limiting toxicities and efficacy of phase I oncology trials: The Cancer Research UK experience. Journal of Clinical Oncology ·Han Hsi Wong, Claire Barton, Gary D Acton, Aakanksha, Ennio Rapisarda, Tonya Baroody Largy, Helen Turner, Susan Wan, Kwang Yih Mah, Lucia Beltramini, Sarah Halford	2015	1
12	Achievement of Renal Function Recovery and Long-Term Graft Survival After Renal Transplantation. Transplantation ·Susan Wan, Marcelo Cantarovich, István Mucsi, Dana Baran, Steven Paraskevas, Jean Tchervenkov	2014	1
13	GRP Receptor Imaging of Prostate Cancer Using [99mTc]Demobesin 4: a First-in-Man Study Molecular Imaging and Biology ·Stephen J. Mather, Berthold A. Nock, Θεοδοσία Μάινα, Yi-Shuan Lin, David H. Ellison, Iain Murray, R. Sobnack, Nathaphon Boonnam, Susan Wan, Constantino Mavrakis, Віктор ХАНИК, Thomas Powles, Norbert Avril	2014	43
14	Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I) British Journal of Cancer ·John Northover, Rob Glynne‐Jones, David Sebag‐Montefiore, R.D. James, Helen Meadows, Susan Wan, Mark Jitlal, JA Ledermann	2010	278
15	A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus (ACT II) Journal of Clinical Oncology ·Lai Shuyi, Susan Wan, R. Glynne‐Jones, David Sebag‐Montefiore, Latha Kadalayil, John Northover, David Cunningham, Helen Meadows, JA Ledermann	2009	31
16	EXTRA—A Multicenter Phase II Study of Chemoradiation Using a 5 Day per Week Oral Regimen of Capecitabine and Intravenous Mitomycin C in Anal Cancer International Journal of Radiation OncologyBiologyPhysics ·Rob Glynne‐Jones, Helen Meadows, Susan Wan, Simon Gollins, Martin Leslie, YU CHEN, Alec McDonald, Sun Myint, Leslie Samuel, David Sebag‐Montefiore	2008	88
17	Thrombolysis Compared With Heparin for the Initial Treatment of Pulmonary Embolism Circulation ·Susan Wan, Daniel J. Quinlan, Giancarlo Agnelli, John W. Eikelboom	2004	377
18	Thromboprophylaxis practice patterns in hip fracture surgery patients: experience in Perth, Western Australia ANZ Journal of Surgery ·Susan Wan, Jeannette W. C. Ting, Huiyu He, Худокормов Георгий Александрович, John W. Eikelboom	2003	8
19	Differential expression of MUC2 and MUC5AC mutin genes in primary ovarian and metastatic colonic carcinoma Human Pathology ·Constance T. Albarracin, И. В. Глебов, Anthony Montag, John Hart, Susan Wan	2000	71
20	Cytokines in myocardial injury: impact on cardiac surgical approach1 European Journal of Cardio-Thoracic Surgery* ·Susan Wan	1999	63

About Susan Wan

Susan Wan is a scholar working on Transplantation, Nephrology, Internal Medicine, Applied Microbiology and Biotechnology and Hepatology, having authored 30 papers that have together received 1.5k indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (5 papers), Colorectal and Anal Carcinomas (4 papers), Organ Transplantation Techniques and Outcomes (4 papers), Renal Diseases and Glomerulopathies (3 papers), Lung Cancer Treatments and Mutations (3 papers), Atrial Fibrillation Management and Outcomes (2 papers), Renal function and acid-base balance (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Internal Medicine (368 citations), Transplantation (119 citations), Critical Care and Intensive Care Medicine (100 citations), Oncology (521 citations) and Surgery (644 citations). Susan Wan has collaborated with scholars based in United Kingdom, Australia and China. Frequent co-authors include John W. Eikelboom, Daniel J. Quinlan, Giancarlo Agnelli, David Sebag‐Montefiore, Helen Meadows, Rob Glynne‐Jones, John Northover, JA Ledermann, R.D. James and Mark Jitlal. Their work appears in journals such as Journal of Clinical Oncology, Transplant International, Transplantation, Chemical Engineering Journal and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact